GERN Q1 2022 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$123,000-10.2% YoY

Gross Profit

-$22M-17866.7% margin

Operating Income

-$29M-23313.0% margin

Net Income

-$30M-24469.9% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

-88.2%

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$34M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$198M

Total Liabilities

$101M

Stockholders' Equity

$97M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$123,000	$137,000	-10.2%
Gross Profit	-$22M	-$21M	-4.8%
Operating Income	-$29M	-$28M	-0.8%
Net Income	-$30M	-$28M	-8.2%